FDA warns of recalled compounded drugs in Michigan

October 22, 2013

The Food and Drug Administration is warning doctors, veterinarians and patients to avoid certain sterile drugs distributed by the Specialty Medicine Compounding Pharmacy of Michigan.

The pharmacy, in South Lyon near Detroit, has recalled drugs distributed in Michigan between July 1 and Oct. 19. The company says no drugs were distributed outside the state.

The specialty pharmacy agreed to conduct the recall after finding floating particles in a sterile that came from a lot that may have been given to hospital patients. The FDA says it's unclear what the particles were.

The FDA recommends doctors and stop using drugs from the pharmacy immediately. For additional details, the public can contact the Specialty Medicine Compounding Pharmacy at 248-446-2643.

No have been reported in connection with the recall.

Explore further: FDA warns of infections tied to Tennessee pharmacy

Related Stories

FDA warns of infections tied to Tennessee pharmacy

May 24, 2013
(AP)—Government health officials are investigating several health problems reported with potentially contaminated medications made by a Tennessee specialty pharmacy.

FDA: Georgia pharmacy recalling all sterile drugs

March 21, 2013
(AP)—The Food and Drug Administration says a Georgia compounding pharmacy that distributed a drug linked to eye infections is now recalling all of its injectable medicines following a federal inspection.

Indianapolis pharmacy recalls compounded drugs

April 23, 2013
(AP)—A pharmacy that makes specialty medications is recalling nearly 100 compounded drugs after federal regulators found potential safety problems during an inspection.

Fla. compounding pharmacy recalls sterile drugs

April 21, 2013
A Florida-based compounding pharmacy is voluntarily recalling all lots of its sterile non-expired drug products sold nationwide over concerns the products are not sterile and may contain bacteria.

US warns of mold in recalled specialty drugs

March 18, 2013
The U.S. Food and Drug Administration warned doctors and hospital managers Monday about a nationwide recall of all drugs made by a New Jersey compounding pharmacy because of possible mold contamination.

FDA warns of another compounding pharmacy recall

March 20, 2013
(AP)—The Food and Drug Administration is warning doctors that a compounding pharmacy is recalling syringes of the Roche drug Avastin after receiving reports of eye infections among patients.

Recommended for you

Study suggests ending opioid epidemic will take years

July 20, 2017
The question of how to stem the nation's opioid epidemic now has a major detailed response. A new study chaired by University of Virginia School of Law Professor Richard Bonnie provides extensive recommendations for curbing ...

Team-based model reduces prescription opioid use among patients with chronic pain by 40 percent

July 17, 2017
A new, team-based, primary care model is decreasing prescription opioid use among patients with chronic pain by 40 percent, according to a new study out of Boston Medical Center's Grayken Center for Addiction Medicine, which ...

Private clinics' peddling of unproven stem cell treatments is unsafe and unethical

July 7, 2017
Stem cell science is an area of medical research that continues to offer great promise. But as this week's paper in Science Translational Medicine highlights, a growing number of clinics around the globe, including in Australia, ...

Popular heartburn drugs linked to higher death risk

July 4, 2017
Popular heartburn drugs called proton pump inhibitors (PPIs) have been linked to a variety of health problems, including serious kidney damage, bone fractures and dementia. Now, a new study from Washington University School ...

Most reproductive-age women using opioids also use another substance

June 30, 2017
The majority of reproductive-age and pregnant women who use opioids for non-medical purposes also use at least one other substance, ranging from nicotine or alcohol to cocaine, according to a University of Pittsburgh Graduate ...

At-risk chronic pain patients taper opioids successfully with psychological tools

June 28, 2017
Psychological support and new coping skills are helping patients at high risk of developing chronic pain and long-term, high-dose opioid use taper their opioids and rebuild their lives with activities that are meaningful ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.